| Active ingredients | Dosage form | Quantity of active ingredients | Shortage status | Availability | Reason | Last updated |
| fenofibrate | Tablet, film coated | 145 mg | Anticipated | Available | Manufacturing | 7/03/2025 |
| zolpidem tartrate | Tablet, film coated | 10 mg | Anticipated | Available | Manufacturing | 7/03/2025 |
| olanzapine pamoate monohydrate | Injection, powder for | 931 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 7/03/2025 |
| olanzapine pamoate monohydrate | Injection, powder for | 690 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 7/03/2025 |
| olanzapine pamoate monohydrate | Injection, powder for | 483 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 7/03/2025 |
| hydroxocobalamin chloride | Injection, solution | 1 mg/mL | Anticipated | Available | Commercial Changes / Commercial viability | 7/03/2025 |
| donepezil hydrochloride | Tablet, film coated | 10 mg | Current | Limited Availability | Manufacturing | 7/03/2025 |
| clopidogrel hydrogen sulfate | Tablet, film coated | 97.9 mg | Current | Limited Availability | Unexpected increase in consumer demand | 7/03/2025 |
| olanzapine | Tablet, orally disintegrating | 5 mg | Current | Limited Availability | Manufacturing | 7/03/2025 |
| sulfamethoxazole~trimethoprim | Tablet, uncoated | 800 mg~160 mg | Current | Limited Availability | Manufacturing | 7/03/2025 |
| clonidine hydrochloride | Tablet, uncoated | 100 microgram | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 7/03/2025 |
| ezetimibe~atorvastatin calcium trihydrate | Tablet, multilayer | 10 mg~86.8 mg | Current | Limited Availability | Manufacturing | 7/03/2025 |
| amiodarone hydrochloride | Injection, solution | 150 mg | Current | Limited Availability | Manufacturing | 7/03/2025 |
| atomoxetine hydrochloride | Capsule, hard | 45.72 mg | Current | Unavailable | Manufacturing | 7/03/2025 |
| atomoxetine hydrochloride | Capsule, hard | 91.44 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 7/03/2025 |
| clonidine hydrochloride | Tablet | 100 microgram | Current | Limited Availability | Unexpected increase in consumer demand | 7/03/2025 |
| dexmedetomidine hydrochloride | Injection, concentrated | 118 microgram/mL | Current | Unavailable | Manufacturing | 7/03/2025 |
| adenosine | Solution | 30 mg | Resolved | Available | Manufacturing | 7/03/2025 |
| escitalopram oxalate | Tablet, film coated | 25.47 mg | Resolved | Available | Manufacturing | 7/03/2025 |
| ezetimibe~atorvastatin calcium trihydrate | Tablet, film coated | 10 mg~82.725 mg | Current | Unavailable | Manufacturing | 7/03/2025 |
| atorvastatin calcium trihydrate~ezetimibe | Tablet, film coated | 82.725 mg~10 mg | Current | Unavailable | Manufacturing | 7/03/2025 |
| lorazepam | Tablet | 2.5 mg | Current | Unavailable | Manufacturing | 7/03/2025 |
| cabergoline | Tablet, uncoated | 2 mg | Current | Unavailable | Manufacturing | 7/03/2025 |
| clonidine hydrochloride | Tablet, uncoated | 150 microgram | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 7/03/2025 |
| norethisterone | Tablet, uncoated | 350 microgram | Resolved | Available | Manufacturing | 6/03/2025 |
| adrenaline (epinephrine) acid tartrate | Injection, solution | 1.82 mg/mL | Current | Unavailable | Manufacturing | 6/03/2025 |
| olanzapine | Tablet, film coated | 10 mg | Current | Limited Availability | Manufacturing | 6/03/2025 |
| mycophenolate mofetil | Tablet, film coated | 500 mg | Current | Unavailable | Manufacturing | 6/03/2025 |
| tacrolimus monohydrate | Capsule, hard | 1.022 mg | Anticipated | Available | Unexpected increase in consumer demand | 6/03/2025 |
| levetiracetam | Tablet, film coated | 1000 mg | Current | Unavailable | Manufacturing | 6/03/2025 |
| trandolapril | Capsule, hard | 1 mg | Current | Unavailable | Manufacturing | 6/03/2025 |
| trandolapril | Capsule, hard | 2 mg | Current | Unavailable | Manufacturing | 6/03/2025 |
| olmesartan medoxomil~amlodipine besilate~hydrochlorothiazide | Tablet | 20 mg~6.944 mg~12.5 mg | Current | Unavailable | Manufacturing | 6/03/2025 |
| hydrochlorothiazide~olmesartan medoxomil~amlodipine besilate | Tablet | 12.5 mg~40 mg~6.944 mg | Current | Limited Availability | Manufacturing | 6/03/2025 |
| duloxetine hydrochloride | Capsule, enteric | 33.65 mg | Resolved | Available | Manufacturing | 6/03/2025 |
| tobramycin | Injection, solution | 40 mg/mL | Current | Unavailable | Unexpected increase in consumer demand | 6/03/2025 |
| mesalazine | Tablet, enteric coated | 800 mg | Resolved | Available | Manufacturing | 6/03/2025 |
| hydrocortisone | Tablet, uncoated | 20 mg | Current | Limited Availability | Manufacturing | 6/03/2025 |
| pregabalin | Capsule, hard | 25 mg | Current | Limited Availability | Manufacturing | 6/03/2025 |
| doxepin hydrochloride | Capsule, hard | 11.3 mg | Current | Limited Availability | Manufacturing | 6/03/2025 |
| mesalazine | Tablet, enteric coated | 1.6 g | Resolved | Available | Manufacturing | 6/03/2025 |
| adrenaline (epinephrine) | Injection, solution | 500 microgram | Anticipated | Available | Manufacturing | 6/03/2025 |
| spironolactone | Tablet, uncoated | 25 mg | Current | Limited Availability | Manufacturing | 6/03/2025 |
| dosulepin (dothiepin) hydrochloride | Capsule, hard | 25 mg | Anticipated | Available | Manufacturing | 6/03/2025 |
| levothyroxine sodium | Tablet, uncoated | 50 microgram | Current | Unavailable | Manufacturing | 6/03/2025 |
| levothyroxine sodium | Tablet, uncoated | .05 mg | Resolved | Available | Unexpected increase in consumer demand | 6/03/2025 |
| naproxen | Tablet | 500 mg | Current | Limited Availability | Manufacturing | 6/03/2025 |
| ethinylestradiol~norethisterone | Tablet, uncoated | 36 microgram~1 mg | Current | Limited Availability | Manufacturing | 6/03/2025 |
| metformin hydrochloride | Tablet, film coated | 850 mg | Current | Unavailable | Manufacturing | 6/03/2025 |
| pioglitazone hydrochloride | Tablet, uncoated | 33.06 mg | Current | Unavailable | Commercial Changes / Commercial viability | 6/03/2025 |
| reboxetine mesilate | Tablet, uncoated | 5.224 mg | Resolved | Available | Manufacturing | 6/03/2025 |
| midazolam | Injection, solution | 5 mg/mL | Current | Limited Availability | Manufacturing | 5/03/2025 |
| acetazolamide sodium | Injection, powder for | 549.5 mg | Current | Unavailable | Manufacturing | 5/03/2025 |
| aripiprazole | Tablet, uncoated | 10 mg | Anticipated | Available | Manufacturing | 5/03/2025 |
| montelukast sodium | Tablet, film coated | 10.4 mg | Anticipated | Available | Manufacturing | 5/03/2025 |
| carboplatin | Injection, solution | 450 mg | Current | Unavailable | Manufacturing | 5/03/2025 |
| ivermectin | Cream | 10 mg/g | Anticipated | Available | Manufacturing | 5/03/2025 |
| tacrolimus monohydrate | Capsule | .767 mg | Current | Unavailable | Manufacturing | 5/03/2025 |
| Follitropin alfa | Injection, solution | 150 IU | Anticipated | Available | Manufacturing | 5/03/2025 |
| citalopram hydrobromide | Tablet, film coated | 49.98 mg | Resolved | Available | Manufacturing | 5/03/2025 |
| ezetimibe | Tablet, uncoated | 10 mg | Current | Limited Availability | Unexpected increase in consumer demand | 5/03/2025 |
| ezetimibe | Tablet, uncoated | 10 mg | Current | Unavailable | Unexpected increase in consumer demand | 5/03/2025 |
| nebivolol hydrochloride | Tablet | 5.45 mg | Resolved | Available | Manufacturing | 5/03/2025 |
| fluorouracil | Injection, solution | 50 mg/mL | Current | Limited Availability | Manufacturing | 5/03/2025 |
| atorvastatin calcium trihydrate | Tablet, film coated | 86.76 mg | Resolved | Available | Manufacturing | 5/03/2025 |
| montelukast sodium | Tablet, chewable | 5.2 mg | Current | Unavailable | Manufacturing | 5/03/2025 |
| lamotrigine | Tablet, chewable | 100 mg | Resolved | Available | Unexpected increase in consumer demand | 5/03/2025 |
| sitagliptin hydrochloride monohydrate~metformin hydrochloride | Tablet, modified release | 56.685 mg~1000 mg | Current | Unavailable | Manufacturing | 5/03/2025 |
| fluorouracil | Cream | 50 mg/g | Current | Unavailable | Manufacturing | 5/03/2025 |
| dexamethasone~gramicidin~framycetin sulfate | Ear Drops | .5 mg/mL~.05 mg/mL~5 mg/mL | Current | Limited Availability | Manufacturing | 5/03/2025 |
| losartan potassium | Tablet, film coated | 50 mg | Current | Unavailable | Unexpected increase in consumer demand | 5/03/2025 |
| cisatracurium besilate | Injection, solution | 6.7 mg/mL | Current | Unavailable | Manufacturing | 5/03/2025 |
| fentanyl | Drug delivery system, transdermal | 8.4 mg | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 4/03/2025 |
| anastrozole | Tablet, film coated | 1 mg | Current | Limited Availability | Manufacturing | 4/03/2025 |
| letrozole | Tablet, film coated | 2.5 mg | Current | Unavailable | Manufacturing | 4/03/2025 |
| rocuronium bromide | Injection, solution | 50 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 4/03/2025 |
| pramipexole dihydrochloride monohydrate | Tablet | 1 mg | Resolved | Available | Manufacturing | 4/03/2025 |
| galantamine hydrobromide | Capsule, modified release | 10.252 mg | Anticipated | Available | Manufacturing | 4/03/2025 |
| azithromycin dihydrate | Tablet, film coated | 524.05 mg | Current | Unavailable | Manufacturing | 4/03/2025 |
| phenoxymethylpenicillin potassium | Tablet, film coated | 280 mg | Resolved | Available | Manufacturing | 4/03/2025 |
| phenoxymethylpenicillin potassium | Tablet, film coated | 560 mg | Resolved | Available | Manufacturing | 4/03/2025 |
| gabapentin | Capsule, hard | 100 mg | Current | Unavailable | Manufacturing | 4/03/2025 |
| adrenaline (epinephrine) acid tartrate | Injection, solution | 182 microgram/mL | Current | Unavailable | Manufacturing | 4/03/2025 |
| noradrenaline (norepinephrine) acid tartrate monohydrate | Injection, concentrated | 4 mg | Current | Limited Availability | Manufacturing | 4/03/2025 |
| citalopram hydrobromide | Tablet, film coated | 12.495 mg | Resolved | Available | Manufacturing | 4/03/2025 |
| imatinib mesilate | Tablet, film coated | 119.5 mg | Current | Unavailable | Unexpected increase in consumer demand | 4/03/2025 |
| ivabradine hydrochloride | Tablet, film coated | 8.085 mg | Anticipated | Available | Manufacturing | 4/03/2025 |
| ivabradine hydrochloride | Tablet, film coated | 5.39 mg | Anticipated | Available | Manufacturing | 4/03/2025 |
| hydrochlorothiazide~olmesartan medoxomil | Tablet | 25 mg~40 mg | Current | Unavailable | Manufacturing | 4/03/2025 |
| fenofibrate | Tablet | 145 mg | Current | Limited Availability | Manufacturing | 4/03/2025 |
| Influenza virus haemagglutinin | Injection, suspension | 15 microgram | Resolved | Available | Seasonal depletion of stock | 4/03/2025 |
| dimethyl fumarate | Capsule, enteric | 120 mg | Current | Unavailable | Manufacturing | 4/03/2025 |
| Influenza virus haemagglutinin | Injection, suspension | 15 microgram | Resolved | Available | Seasonal depletion of stock | 4/03/2025 |
| montelukast sodium | Tablet, film coated | 10.4 mg | Current | Limited Availability | Manufacturing | 4/03/2025 |
| phenoxymethylpenicillin potassium | Capsule, hard | 554.37 mg | Resolved | Available | Manufacturing | 4/03/2025 |
| phenoxymethylpenicillin potassium | Capsule, hard | 277.18 mg | Resolved | Available | Manufacturing | 4/03/2025 |
| lamotrigine | Tablet, chewable | 200 mg | Resolved | Available | Unexpected increase in consumer demand | 4/03/2025 |
| lacosamide | Tablet, film coated | 150 mg | Current | Unavailable | Manufacturing | 4/03/2025 |
| melatonin | Capsule, hard | 3 mg | Current | Limited Availability | Unexpected increase in consumer demand | 4/03/2025 |
| methylphenidate hydrochloride | Tablet, uncoated | 10 mg | Resolved | Available | Manufacturing | 3/03/2025 |
| gabapentin | Tablet, film coated | 800 mg | Current | Unavailable | Manufacturing | 3/03/2025 |
| silver sulfadiazine | Cream | 10 mg/g | Resolved | Available | Manufacturing | 3/03/2025 |
| silver sulfadiazine | Cream | 10 mg/g | Resolved | Available | Manufacturing | 3/03/2025 |
| human menopausal gonadotrophin | Injection, powder for | 600 IU | Current | Limited Availability | Manufacturing | 3/03/2025 |
| human menopausal gonadotrophin | Injection, powder for | 1200 IU | Current | Limited Availability | Manufacturing | 3/03/2025 |
| progesterone | Pessary, compressed | 100 mg | Resolved | Available | Manufacturing | 3/03/2025 |
| midazolam | Injection, solution | 5 mg | Resolved | Available | Manufacturing | 3/03/2025 |
| methotrexate | Injection, solution | 100 mg/mL | Current | Unavailable | Manufacturing | 3/03/2025 |
| fenofibrate | Tablet | 48 mg | Current | Limited Availability | Manufacturing | 3/03/2025 |
| olmesartan medoxomil~hydrochlorothiazide | Tablet | 20 mg~12.5 mg | Current | Unavailable | Manufacturing | 3/03/2025 |
| acamprosate calcium | Tablet, enteric coated | 333 mg | Current | Limited Availability | Unexpected increase in consumer demand | 3/03/2025 |
| mefenamic acid | Capsule, hard | 250 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 3/03/2025 |
| lurasidone hydrochloride | Tablet, film coated | 80 mg | Current | Unavailable | Manufacturing | 3/03/2025 |
| carmustine~ethanol absolute | Diluent, not applicable~Injection, powder for | 100 mg~3 mL | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 3/03/2025 |
| sitagliptin hydrochloride monohydrate~metformin hydrochloride | Tablet, film coated | 56.69 mg~1000 mg | Current | Unavailable | Manufacturing | 3/03/2025 |
| carboplatin | Injection, solution | 10 mg/mL | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 3/03/2025 |
| timolol maleate~dorzolamide hydrochloride | Eye Drops, solution | 6.83 mg/mL~22.26 mg/mL | Current | Unavailable | Manufacturing | 3/03/2025 |
| tobramycin | Injection, solution | 40 mg/mL | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 3/03/2025 |
| estradiol hemihydrate | Drug delivery system, transdermal | 2.32 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 3/03/2025 |
| nizatidine | Capsule | 150 mg | Current | Limited Availability | Manufacturing | 3/03/2025 |
2025年3月9日